Dasatinib Tablet 100 Mg

Name: Dasatinib Tablet 100 Mg
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 2630.0 INR
Availability: InStock

Price 2630.0 INR/ Box

Get a Price/Quote

MOQ : 5 Boxes

Dasatinib Tablet 100 Mg Specification

Dosage Form
Tablet

Packaging Type
Bottle

Brand Name
Spnib

Indication
Chronic Myeloid Leukemia

Life Span
See expiry on pack

Salt Composition
Dasatinib

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 Tablets

Drug Type
Allopathic

Ingredients
Dasatinib

Physical Form
Tablet

Function
Anti-Cancer

Recommended For
Chronic Myeloid Leukemia (CML)

Dosage
100 mg

Dosage Guidelines
As prescribed by physician

Suitable For
Adults

Quantity
30 Tablets

Storage Instructions
Store below 30C

Therapeutic Class
Antineoplastic

Marketed By
Zydus Oncosciences

Prescription Required
Yes

Oral Administration
Yes

Dasatinib Tablet 100 Mg Trade Information

Minimum Order Quantity
5 Boxes

Supply Ability
500 Boxes Per Month

Delivery Time
7 Days

Dasatinib Tablet 100 Mg About

Experience the impeccable efficacy of Spnib Dasatinib Tablet 100 mg, a best-seller in cancer therapy and widely trusted by healthcare professionals. Masterfully formulated by Zydus Oncosciences, each bottle contains 30 tablets designed for oral administration, delivering astonishing results for adults battling Chronic Myeloid Leukemia (CML). This limited stock, allopathic masterpiece comes with the assurance of premium quality from one of India's top exporters, manufacturers, and suppliers. Personalise your treatment under physician guidance and secure your chance to benefit from a reliable anti-cancer solution today.

Diverse Use and Beneficiaries of Dasatinib Tablet 100 Mg

Dasatinib Tablet 100 Mg is revered for its impeccable role in managing Chronic Myeloid Leukemia (CML), but its applications extend to patients with Ph+ acute lymphoblastic leukemia in specific situations. Used primarily by adult patients, it is recommended for those requiring sophisticated antineoplastic therapies. Healthcare professionals rely on this tablet to deliver optimal results in cancer management, offering hope to individuals in need of effective oncology solutions.

Market Access, Sample Policy, and Logistics

The arrival of Dasatinib Tablet 100 Mg in major Indian markets assures access to life-saving medication at the lowest price available. Sample units can be provided upon request for assessment. With reliable goods transport and strong supply ability, Zydus Oncosciences streamlines order fulfillment, ensuring timely delivery not just locally but internationally as well. Buyers can confidently rely on consistent stock availability and efficient logistics to meet urgent treatment demands.

FAQ's of Dasatinib Tablet 100 Mg:

Q: How should Dasatinib Tablet 100 Mg be taken for optimal results?

A: Dasatinib Tablet 100 Mg should be administered orally as prescribed by your physician. It is important to follow the recommended dosage and never self-adjust the dose without professional guidance.

Q: What is Dasatinib Tablet 100 Mg used for?

A: This medication is primarily indicated for the treatment of chronic myeloid leukemia (CML) and may be used in certain cases of Ph+ acute lymphoblastic leukemia, depending on the physician's assessment.

Q: When should a patient consider starting Dasatinib therapy?

A: Initiation of Dasatinib therapy should be considered when diagnosed with CML and upon the explicit recommendation and prescription of a qualified healthcare provider.

Q: Where can I purchase Dasatinib Tablet 100 Mg?

A: Dasatinib Tablet 100 Mg, branded as Spnib by Zydus Oncosciences, can be sourced through licensed pharmacies and medical suppliers, especially in India and international markets where the supplier is authorized.

Q: What storage instructions are required for Dasatinib Tablet 100 Mg?

A: The tablets should be stored below 30C in a cool, dry place. Always check the expiry date on the package and keep them out of reach of children.

Q: How does Dasatinib Tablet 100 Mg benefit patients with CML?

A: By targeting specific cancerous cells, Dasatinib helps inhibit the progression of CML, potentially improving patient outcomes and offering another line of defense against the disease when prescribed appropriately.

Tell us about your requirement